Evidence map›Paper›PMID 22270356›Full record

ArticleEcotoxicology (London, England)2012

Sequencing and structural homology modeling of the ecdysone receptor in two chrysopids used in biological control of pest insects.

Moises João Zotti, Olivier Christiaens, Pierre Rougé, Anderson Dionei Grutzmacher, Paulo Dejalma Zimmer, Guy Smagghe

Abstract read
PubMed Publisher
In one paragraph

Article in Ecotoxicology (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moises João ZottiLaboratory of Agrozoology, Department of Crop Protection, Ghent University, 9000 Ghent, Belgium. mzotti.faem@ufpel.tche.br
Olivier Christiaens
Pierre Rougé
Anderson Dionei Grutzmacher
Paulo Dejalma Zimmer
Guy Smagghe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In insects, the process of molting and metamorphosis are mainly regulated by a steroidal hormone 20-hydroxyecdysone (20E) and its analogs (ecdysteroids) that specifically bind to the ecdysone receptor ligand-binding domain (EcR-LBD). Currently, several synthetic non-steroidal ecdysone agonists, including tebufenozide, are commercially available as insecticides. Tebufenozide exerts its activity by binding to the 20E-binding site and thus activating EcR permanently. It appears that subtle differences in the architecture among LBDs may underpin the differential binding affinity of tebufenozide across taxonomic orders. In brief, first we demonstrated the harmlessness of tebufenozide towards Chrysoperla externa (Ce). Then, a molecular analysis of EcR-LBD of two neuropteran insects Chrysoperla carnea and Ce was presented. Finally, we constructed a chrysopid in silico homology model docked ponasterone A (PonA) and tebufenozide into the binding pocket and analyzed the amino acids indentified as critical for binding to PonA and tebufenozide. Due to a restrict extent in the cavity at the bottom of the ecdysone-binding pocket a steric clash occurred upon docking of tebufenozide. The absence of harm biological effect and the docking results suggest that tebufenozide is prevented of any deleterious effects on chrysopids.

Indexed as

Amino Acid SequenceAnimalsBinding SitesComputational BiologyEcdysoneEcdysteroneHydrazinesInsectaInsecticidesJuvenile HormonesMolecular ConformationMolecular Sequence DataPest Control, BiologicalReceptors, SteroidEcdysoneecdysone receptorEcdysteroneHydrazinesInsecticidesJuvenile Hormonesponasterone AReceptors, Steroidtebufenozide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.